Institution: Alaska Permanent Fund
Headquarters: Juneau, United States
Allocation to alternatives: 27.33%
Alaska Permanent Fund has committed $50 million to Altitude Life Science Ventures Side Fund III, $15 million to Genstar Capital Partners IX, $40 million to Summit Partners Growth Equity Fund X, $50 million to L Catteron Growth IV and $15 million to Nautic Partners IX. The five funds all invest in North American companies within several industries, including healthcare, business services, biotechnology and life sciences.
The US sovereign wealth fund has a 12% target allocation to private equity that currently stands at 12.86%.
As illustrated in the charts below, APFC currently allocates 27.33% to alternative assets. The fund has a strong appetite for healthcare and biotechnology vehicles.
Platinum subscribers may click here for the investor’s full profile, including key contacts, allocation strategy and fund investments.